Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

By U. Veronesi, R. Orecchia, P. Maisonneuve, G. Viale, N. Rotmensz, C. Sangalli, A. Luini, P. Veronesi, V. Galimberti, S. Zurrida and 7 more. The Lancet Oncology, 2013

729 citations recorded by the source corpus.

Subfields: Cancer Research, Pathology and Forensic Medicine, Radiation

View Paper: https://www.semanticscholar.org/paper/b99ae28fe6ceb606f1f72f339347d6de09e862a3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Rutgers

Citations in the corpus

• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, result): “However, in the ELIOT (single dose of electrons) and TARGIT (single intra-operative dose 50 kV X-rays) randomised trials, the ipsilateral breast recurrence rate was significantly higher in the APBI groups, compared with the WBRT trial [72, 73].”